Berberine in combination with doxorubicin suppresses growth of murine melanoma B16F10 cells in culture and xenograft - PubMed (original) (raw)
. 2014 Feb 15;21(3):340-7.
doi: 10.1016/j.phymed.2013.09.002. Epub 2013 Oct 28.
Affiliations
- PMID: 24176840
- DOI: 10.1016/j.phymed.2013.09.002
Berberine in combination with doxorubicin suppresses growth of murine melanoma B16F10 cells in culture and xenograft
Anil Mittal et al. Phytomedicine. 2014.
Abstract
Melanoma is very aggressive and major cause of mortality due to skin cancer. Herein, we studied the anticancer effects of berberine, a plant alkaloid, in combination with doxorubicin on murine melanoma B16F10 cells in vitro and in vivo. This drug combination strongly inhibited cell growth and induced cell death, and caused G2/M arrest in cell cycle together with a decrease in Kip1/p27. Berberine showed stronger inhibitory effect on ERK1/2 phosphorylation as compared to Akt phosphorylation, whereas the combination of the drugs showed greater inhibitory effect on Akt phosphorylation. In murine B16F10 xenograft, cells were implanted into mice and treated with vehicle (methyl cellulose) or berberine (100mg/kg of body weight/day by oral gavage) or doxorubicin (4 mg/kg of body weight/week by intraperitoneal injection) or combination of berberine and doxorubicin. Berberine alone did not show any considerable effect on tumor growth as observed with doxorubicin, however, the combination of the two drugs resulted in a significant and strong decrease in tumor volume (85%, p<0.005) and tumor weight (78%, p<0.05) as compared to control. Immunohistochemical analysis of tumor samples showed that drug combination decreased PCNA-positive cells (82%, p<0.001) and increased cleaved caspase-3 positive cells (3-fold, p<0.05) indicating inhibition of proliferation and an increase in apoptosis, respectively. Overall, our findings suggest that berberine and doxorubicin could be a novel combination to inhibit melanoma tumor growth.
Keywords: Berberine; Doxorubicin; Murine melanoma cells; Xenograft transplantation.
Copyright © 2013 Elsevier GmbH. All rights reserved.
Similar articles
- Berberine inhibits human tongue squamous carcinoma cancer tumor growth in a murine xenograft model.
Ho YT, Yang JS, Lu CC, Chiang JH, Li TC, Lin JJ, Lai KC, Liao CL, Lin JG, Chung JG. Ho YT, et al. Phytomedicine. 2009 Sep;16(9):887-90. doi: 10.1016/j.phymed.2009.02.015. Epub 2009 Mar 20. Phytomedicine. 2009. PMID: 19303753 - The alkaloid Berberine inhibits the growth of Anoikis-resistant MCF-7 and MDA-MB-231 breast cancer cell lines by inducing cell cycle arrest.
Kim JB, Yu JH, Ko E, Lee KW, Song AK, Park SY, Shin I, Han W, Noh DY. Kim JB, et al. Phytomedicine. 2010 May;17(6):436-40. doi: 10.1016/j.phymed.2009.08.012. Epub 2009 Oct 2. Phytomedicine. 2010. PMID: 19800775 - Plumbagin induces cell cycle arrest and apoptosis through reactive oxygen species/c-Jun N-terminal kinase pathways in human melanoma A375.S2 cells.
Wang CC, Chiang YM, Sung SC, Hsu YL, Chang JK, Kuo PL. Wang CC, et al. Cancer Lett. 2008 Jan 18;259(1):82-98. doi: 10.1016/j.canlet.2007.10.005. Epub 2007 Nov 19. Cancer Lett. 2008. PMID: 18023967 - Targets and mechanisms of berberine, a natural drug with potential to treat cancer with special focus on breast cancer.
Jabbarzadeh Kaboli P, Rahmat A, Ismail P, Ling KH. Jabbarzadeh Kaboli P, et al. Eur J Pharmacol. 2014 Oct 5;740:584-95. doi: 10.1016/j.ejphar.2014.06.025. Epub 2014 Jun 26. Eur J Pharmacol. 2014. PMID: 24973693 Review. - Berberine: A potential adjunct for the treatment of gastrointestinal cancers?
Hesari A, Ghasemi F, Cicero AFG, Mohajeri M, Rezaei O, Hayat SMG, Sahebkar A. Hesari A, et al. J Cell Biochem. 2018 Dec;119(12):9655-9663. doi: 10.1002/jcb.27392. Epub 2018 Aug 20. J Cell Biochem. 2018. PMID: 30125974 Review.
Cited by
- Decursinol Angelate Arrest Melanoma Cell Proliferation by Initiating Cell Death and Tumor Shrinkage via Induction of Apoptosis.
Chang SN, Khan I, Kim CG, Park SM, Choi DK, Lee H, Hwang BS, Kang SC, Park JG. Chang SN, et al. Int J Mol Sci. 2021 Apr 15;22(8):4096. doi: 10.3390/ijms22084096. Int J Mol Sci. 2021. PMID: 33921050 Free PMC article. - Role of host β1- and β2-adrenergic receptors in a murine model of B16 melanoma: functional involvement of β3-adrenergic receptors.
Sereni F, Dal Monte M, Filippi L, Bagnoli P. Sereni F, et al. Naunyn Schmiedebergs Arch Pharmacol. 2015 Dec;388(12):1317-31. doi: 10.1007/s00210-015-1165-7. Epub 2015 Aug 19. Naunyn Schmiedebergs Arch Pharmacol. 2015. PMID: 26285646 - Hyperthermia Enhances Doxorubicin Therapeutic Efficacy against A375 and MNT-1 Melanoma Cells.
Salvador D, Bastos V, Oliveira H. Salvador D, et al. Int J Mol Sci. 2021 Dec 21;23(1):35. doi: 10.3390/ijms23010035. Int J Mol Sci. 2021. PMID: 35008457 Free PMC article. - Current Advancements and Novel Strategies in the Treatment of Metastatic Melanoma.
Sood S, Jayachandiran R, Pandey S. Sood S, et al. Integr Cancer Ther. 2021 Jan-Dec;20:1534735421990078. doi: 10.1177/1534735421990078. Integr Cancer Ther. 2021. PMID: 33719631 Free PMC article. Review. - Didox and resveratrol sensitize colorectal cancer cells to doxorubicin via activating apoptosis and ameliorating P-glycoprotein activity.
Khaleel SA, Al-Abd AM, Ali AA, Abdel-Naim AB. Khaleel SA, et al. Sci Rep. 2016 Nov 14;6:36855. doi: 10.1038/srep36855. Sci Rep. 2016. PMID: 27841296 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous